Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable
bleeding symptoms and thrombocytopenia. In the last decade, changes in our …

Splenectomy is an effective therapy for steroid-refractory or dependent immune
thrombocytopenia (ITP). With the advent of medical alternatives such as rituximab and …

Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …

Immune thrombocytopenia (ITP) has historically been thought to occur in 2 distinct forms:
childhood ITP and adult ITP. This division is based largely on the presumption that …

Although splenectomy is still considered the most effective curative treatment for immune
thrombocytopenia (ITP), its use has significantly declined in the last decade, especially since …

Chronic primary immune thrombocytopenia (ITP) can today benefit from multiple therapeutic
approaches with proven clinical efficacy, including rituximab, thrombopoietin receptor …

Since early 1990's, when it was inaugurally introduced, laparoscopic splenectomy has been
performed with excellent results in terms of intraoperative and postoperative complications …

Persistent immune thrombocytopenia (ITP) patients require second‐line treatments, for
which information on clinical outcomes are lacking. A systematic review and network meta …

Background Splenectomy is commonly used to treat refractory immune–mediated cytopenia,
but there are no established factors that are associated with response to the procedure …

Immune thrombocytopenia (ITP) is an autoimmune disorder that induces a decrease in the
number of circulating platelets due to spleen destruction and inability of megakaryocytes to …